These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP. Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224 [Abstract] [Full Text] [Related]
3. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection. Patschan D, Kribben A, Pietruck F, Lutz J, Binek M, Philipp T, Heemann U, Witzke O. Nephron Clin Pract; 2006 Mar 27; 103(3):c94-9. PubMed ID: 16534238 [Abstract] [Full Text] [Related]
11. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J. Transplantation; 1996 Sep 15; 62(5):594-9. PubMed ID: 8830821 [Abstract] [Full Text] [Related]
12. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Millis JM, Bruce DS, Newell KA, Piper JB, Woodle ES, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR. Transplant Proc; 1996 Apr 15; 28(2):1014. PubMed ID: 8623213 [No Abstract] [Full Text] [Related]
13. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P. J Pediatr Surg; 1997 May 15; 32(5):688-90. PubMed ID: 9165452 [Abstract] [Full Text] [Related]
14. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J. Transplantation; 2000 Jun 27; 69(12):2573-80. PubMed ID: 10910279 [Abstract] [Full Text] [Related]
16. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P. Transplant Proc; 1995 Feb 27; 27(1):1111-3. PubMed ID: 7533357 [No Abstract] [Full Text] [Related]
17. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. Yamani MH, Starling RC, Pelegrin D, Platt L, Majercik M, Hobbs RE, McCarthy P, Young JB. J Heart Lung Transplant; 2000 Apr 27; 19(4):337-42. PubMed ID: 10775813 [Abstract] [Full Text] [Related]
18. OKT3 rescue for steroid-resistant rejection in adult liver transplantation. Solomon H, Gonwa TA, Mor E, Holman MJ, Gibbs J, Watemberg I, Netto G, Goldstein RM, Husberg BS, Klintmalm GB. Transplantation; 1993 Jan 27; 55(1):87-91. PubMed ID: 8420070 [Abstract] [Full Text] [Related]
19. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? Dé P, Bechstein WO, Blumhardt G, Lange D, Schattenfroh N, Neuhaus P. Transplant Proc; 1993 Aug 27; 25(4):2693-4. PubMed ID: 7689279 [No Abstract] [Full Text] [Related]
20. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Jordan ML, Naraghi R, Shapiro R, Smith D, Vivas CA, Scantlebury VP, Gritsch HA, McCauley J, Randhawa P, Demetris AJ, McMichael J, Fung JJ, Starzl TE. Transplantation; 1997 Jan 27; 63(2):223-8. PubMed ID: 9020321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]